register

News & Trends - MedTech & Diagnostics

RPA, The Alfred and Royal North Shore Hospital top the list of ‘best hospitals’

Health Industry Hub | March 3, 2023 |

COVID-19 placed significant stress on the health system, as has inflation and global financial uncertainty. Leading hospitals are dealing with rising costs, aging populations and a medical workforce exhausted from battling a global pandemic.

The best hospitals consistently attract the best people and provide the best outcomes for patients as well as the most important new therapies and research. The very best institutions also share another quality – consistency. 

Royal Prince Alfred Hospital (RPA) has once again been ranked as the best hospital in Australia in Newsweek’s 2023 World’s Best Hospitals list. It’s the second year in a row that RPA has claimed the top spot in the country.

RPA is ranked at number 66 globally, in the list of the top 250 hospitals in the world, a jump from last year when it was ranked at number 71.

Only seven Australian hospitals are ranked in the top 250 hospitals in the world.

“I couldn’t be prouder of everyone who works at RPA. Our staff throughout the hospital, regardless of what they do, work tirelessly to provide the very best care to our patients and their families and that’s what’s been reflected with this award. It is an honour to be shared by every member of staff” Kiel Harvey, RPA’s General Manager, said.

This result is recognition of RPA’s emphasis on patient-centred care, said Kylie Tastula, Nurse Practitioner in Neurosciences at RPA.

“It is a privilege to come to work in a place that puts the patient at the centre of what we do. Everyone here works to innovate and drive change but they never lose sight of what’s most important – the people we care for,” she said.

RPA’s success is down to research and innovation at the hospital coupled with its focus on patients and their carers, added Dr Steve Chadban, Director of Renal Medicine at RPA.

“Together with our strong culture of education, collaboration, respect and support for all of our staff, I believe we are well placed to continue to provide our patients with the best possible care and world-class outcomes,” he said.

“The results are a recognition of our District’s continued focus on research and innovation which enables us to deliver world-class patient care,” said Sydney Local Health District Chief Executive, Dr Teresa Anderson AM.

“The results are also a testament to the hard work, dedication and resilience of all our staff who work daily to make a difference for our patients, their families and our community.”

The 2023 list ranks more than 2300 hospitals in 28 countries including the United States, the United Kingdom and in Europe. It is based on recommendations from medical experts, patient experience survey results, hospital quality metrics and PROMs implementation data.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.